FDA-APPROVED WEIGHT LOSS DRUGS - AN OVERVIEW

At an FDA advisory panel hearing held in September to overview liraglutide's probable obesity indication, David W Cooke, MD, associate professor of pediatrics and medical director of pediatric endocrinology at Johns Hopkins University, Baltimore, Maryland, stated, "I believed the info incredibly Plainly supported efficacy regarding weight loss, no